Keywords: Bristol-Myers Squibb, Orencia, UK, NICE, Earlier use, Rheumatoid arthritis

NICE green light for earlier use of Bristol-Myers' Orencia

Article | 08 March 2013

Print This

The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) now recommends the National Health Service use ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in